Evidence map›Paper›PMID 36782237›Full record

ArticleCell communication and signaling : CCS2023

A novel isolation method for spontaneously released extracellular vesicles from brain tissue and its implications for stress-driven brain pathology.

Patrícia A Gomes, Cristian Bodo, Carlos Nogueras-Ortiz, Martina Samiotaki, Minghao Chen, Carina Soares-Cunha, Joana M Silva, Bárbara Coimbra, George Stamatakis, Liliana Santos and 8 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Cell communication and signaling : CCS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Research advances of tissue-derived extracellular vesicles in cancers.Journal of cancer research and clinical oncology · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Patrícia A GomesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0001-7130-3445
Cristian BodoSystems Oncology Group, Champalimaud Research, Champalimaud Centre for the Unknown, Av. Brasília, 1400-038, Lisbon, Portugal.ORCID 0000-0001-8521-8276
Carlos Nogueras-OrtizLaboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD, USA.ORCID 0000-0003-2503-965X
Martina SamiotakiInstitute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", 16672, Vari, Attica, Greece.ORCID 0000-0001-9952-0636
Minghao ChenCenter for Soft Nanoscience and Institute of Medical Physics and Biophysics, University of Muenster, 48149, Münster, Germany.
Carina Soares-CunhaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0001-9470-644X
Joana M SilvaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0002-8257-3413
Bárbara CoimbraLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0003-1737-2268
George StamatakisInstitute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", 16672, Vari, Attica, Greece.ORCID 0000-0002-3459-4383
Liliana SantosLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0002-9167-8241
George PanayotouInstitute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", 16672, Vari, Attica, Greece.
Foteini TzouanouInstitute of Biosciences and Applications NCSR "Demokritos", Athens, Greece.ORCID 0000-0002-5836-7900
Clarissa L WaitesDepartment of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0003-4263-5576
Christos GatsogiannisCenter for Soft Nanoscience and Institute of Medical Physics and Biophysics, University of Muenster, 48149, Münster, Germany.ORCID 0000-0002-4922-4545
Nuno SousaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.ORCID 0000-0002-8755-5126
Dimitrios KapogiannisLaboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD, USA.ORCID 0000-0003-2181-3118
Bruno Costa-SilvaSystems Oncology Group, Champalimaud Research, Champalimaud Centre for the Unknown, Av. Brasília, 1400-038, Lisbon, Portugal. bruno.costa-silva@research.fchampalimaud.org.ORCID 0000-0002-5932-6211
Ioannis SotiropoulosLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal. ioannis@med.uminho.pt.ORCID 0000-0003-0115-0038
University of Minho · PTAlexander Fleming Biomedical Sciences Research Center · GRChampalimaud Foundation · PTNational Centre of Scientific Research "Demokritos" · GRNational Institute on Aging · USUniversity of Münster · DEColumbia University Irving Medical Center · US

Funding

Studies in Dementia and Neurodegenerative DiseasesZIAAG000975 · NIA · NATIONAL INSTITUTE ON AGING · PI KAPOGIANNIS, DIMITRIOS · 2009 to 2025
$31.5M
Uncovering stress-induced mechanisms of Tau pathology in Alzheimer's diseaseRF1AG069941 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Clarissa Leigh Waites · 2020 to 2026
$5.5M
Uncovering stress-induced mechanisms of Tau pathology in Alzheimer's diseaseR01AG069941 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WAITES, CLARISSA LEIGH · 2024 to 2024
$552k
NIA NIH HHS R01 AG069941NIA NIH HHS RF1 AG069941
6 · The paper itself

Abstract

backgroundExtracellular vesicles (EVs), including small EVs (sEVs) such as exosomes, exhibit great potential for the diagnosis and treatment of brain disorders, representing a valuable tool for precision medicine. The latter demands high-quality human biospecimens, especially in complex disorders in which pathological and specimen heterogeneity, as well as diverse individual clinical profile, often complicate the development of precision therapeutic schemes and patient-tailored treatments. Thus, the collection and characterization of physiologically relevant sEVs are of the utmost importance. However, standard brain EV isolation approaches rely on tissue dissociation, which can contaminate EV fractions with intracellular vesicles.

methodsBased on multiscale analytical platforms such as cryo-EM, label-free proteomics, advanced flow cytometry, and ExoView analyses, we compared and characterized the EV fraction isolated with this novel method with a classical digestion-based EV isolation procedure. Moreover, EV biogenesis was pharmacologically manipulated with either GW4869 or picrotoxin to assess the validity of the spontaneous-release method, while the injection of labelled-EVs into the mouse brain further supported the integrity of the isolated vesicles.

resultsWe hereby present an efficient purification method that captures a sEV-enriched population spontaneously released by mouse and human brain tissue. In addition, we tested the significance of the release method under conditions where biogenesis/secretion of sEVs was pharmacologically manipulated, as well as under animals' exposure to chronic stress, a clinically relevant precipitant of brain pathologies, such as depression and Alzheimer's disease. Our findings show that the released method monitors the drug-evoked inhibition or enhancement of sEVs secretion while chronic stress induces the secretion of brain exosomes accompanied by memory loss and mood deficits suggesting a potential role of sEVs in the brain response to stress and related stress-driven brain pathology.

conclusionsOverall, the spontaneous release method of sEV yield may contribute to the characterization and biomarker profile of physiologically relevant brain-derived sEVs in brain function and pathology. Video Abstract.

Indexed as

Alzheimer DiseaseExosomesExtracellular VesiclesAnimalsBiomarkersBrainHumansMiceBiomarkersBrainExosomesExtracellular vesiclesHumanMouseSpontaneous releaseStress

Identifiers

PMID36782237
PMCPMC9926669
OpenAlexW4320486429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.